In the Media

A new study on cancer drug development by MIT researchers found that pharmaceutical firms overlook drugs for early-stage tumors, writes Jordan Graham for The Boston Herald. “There’s dramatically more investments in the late-stage treatments,” says Prof. Benjamin Roin.